Frontiers in Synaptic Neuroscience, published by FRONTIERS MEDIA SA, is a leading open-access journal that has been at the forefront of advancing knowledge in the fields of neuroscience and cellular biology since its inception in 2010. With an ISSN and E-ISSN of 1663-3563, this journal aims to disseminate high-quality research focused on the structural and functional mechanisms of synapses and their role in neural communication. The journal's reputation is underscored by its impressive standing in the academic community, evidenced by its 2023 category quartiles: Q2 in Cell Biology and Q1 in Cellular and Molecular Neuroscience. It holds a noteworthy position within Scopus ranks, being placed 35th out of 97 in its primary category, showcasing its relevance to both established and emerging researchers in the field. Operating from its office in Lausanne, Switzerland, this journal fosters collaboration and knowledge exchange while supporting the principles of open access, allowing wide dissemination and accessibility of groundbreaking research. With a converged publication timeline extending from 2009 to 2024, Frontiers in Synaptic Neuroscience continues to be an invaluable resource for professionals and students alike, eager to explore the complexities of synaptic function and its implications for neural networks.

NEUROBIOLOGY OF DISEASE is a premier journal dedicated to advancing the understanding of neurological disorders and the underlying biological processes, published by Academic Press Inc, Elsevier Science. With an impressive impact factor indicative of its significance—ranked in the Q1 quartile in Neurology for 2023 and occupying the 14th rank out of 192 journals in the field of Neuroscience and Neurology—this journal serves as a critical resource for researchers, clinicians, and students alike. The journal has a rich history since its inception in 1994, continuously evolving its scope to encompass groundbreaking research and insights into neurobiological mechanisms and disease pathology. Though it currently does not provide Open Access options, NEUROBIOLOGY OF DISEASE remains a vital vessel for disseminating knowledge that significantly contributes to the field of neurology, fostering an understanding that can lead to innovative therapeutic strategies.

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

NEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.

Welcome to Molecular Neurobiology, the premier journal dedicated to the exploration of the molecular mechanisms underlying nervous system function and pathophysiology. Published by Springer, this journal provides an essential platform for disseminating high-quality research in the rapidly evolving fields of Cellular and Molecular Neuroscience and Neurology, boasting an impressive impact factor that reflects its esteemed position within the academic community. With its ranking in the Q1 and Q2 quartiles for various neuroscience categories, Molecular Neurobiology stands at the forefront of groundbreaking discoveries, showcasing innovative studies that bridge basic science and clinical application. Researchers and professionals are invited to contribute to its rich portfolio, which spans from fundamental insights into cellular processes to advanced therapeutic strategies. Although Molecular Neurobiology does not operate as an Open Access journal, its influential body of work remains accessible through institutional and personal subscriptions. As we converge from 1987 to 2024, we continue to aim for excellence, seeking to catalyze progress in understanding neurological diseases and enhance the scientific dialogue within the neuroscience community.

Molecular Neurodegeneration is a leading journal published by BMC, dedicated to advancing the field of neurodegeneration through high-quality, open-access research. Since its inception in 2006, this peer-reviewed journal has provided a pivotal platform for the dissemination of innovative findings in the realms of Cellular and Molecular Neuroscience, Molecular Biology, and Clinical Neurology. With a stellar impact factor and listed in the prestigious Q1 category in multiple relevant categories, it ranks among the top publications in the field—specifically, it holds the #3 position in Neuroscience and #6 position in Clinical Neurology based on Scopus metrics. Researchers, professionals, and students alike will find significant value in the open access format, which fosters unrestricted sharing of knowledge, ensuring that emerging ideas in neurodegeneration reach a global audience. Based in London, United Kingdom, the journal promises a comprehensive scope that addresses critical questions in neurobiology, making it an essential resource for anyone interested in the molecular mechanisms underlying neurodegenerative diseases.

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.

ACTA NEUROBIOLOGIAE EXPERIMENTALIS, an esteemed journal published by the Nencki Institute of Experimental Biology in Poland, has been a pivotal platform for the dissemination of research in the fields of medicine and neuroscience since its inception in 1970. With an ISSN of 0065-1400 and an E-ISSN of 1689-0035, this journal has consistently aimed to contribute to the understanding of neurobiological phenomena, cementing its status within the academic community. Despite its current categorization in the Q3 and Q4 quartiles for Medicine and Neuroscience respectively, ACTA NEUROBIOLOGIAE EXPERIMENTALIS continues to uphold rigorous scientific standards, providing an invaluable resource for researchers, professionals, and students alike. As an essential scholarly outlet, it encourages the exploration of groundbreaking findings and clinical applications in neurobiology, making it an attractive choice for those eager to advance their understanding of this intricate field.

FASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.

SYNAPSE, an esteemed journal in the field of Cellular and Molecular Neuroscience, is published by Wiley and serves as a vital platform for disseminating groundbreaking research in neuroscience. Established in 1987, this journal has been pivotal in exploring the intricate mechanisms governing synaptic function and neural communication, contributing to our understanding of the nervous system. With an ISSN of 0887-4476 and an E-ISSN of 1098-2396, SYNAPSE is indexed in Scopus and currently holds a Q4 quartile ranking in its category, reflecting its niche yet significant presence within the research community. Despite its recent ranking in the 21st percentile among its peers, the journal’s commitment to quality and innovation remains unwavering. It is published from Hoboken, New Jersey, and although it is not an open-access journal, it provides invaluable insights and critical reviews that are pivotal for researchers, professionals, and students alike who seek to advance their knowledge in the dynamic field of neuroscience. Join us in contributing to the ever-evolving discourse in cellular and molecular neuroscience through SYNAPSE.